BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23555867)

  • 1. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
    Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
    PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Adrenergic receptor expression in vascular tumors.
    Chisholm KM; Chang KW; Truong MT; Kwok S; West RB; Heerema-McKenney AE
    Mod Pathol; 2012 Nov; 25(11):1446-51. PubMed ID: 22743651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.
    Miettinen M; Sarlomo-Rikala M; Wang ZF
    Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
    Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
    Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
    Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD
    EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.
    Heinhuis KM; IJzerman NS; Koenen AM; van der Graaf WTA; Haas RL; Beijnen JH; Huitema ADR; van Houdt WJ; Steeghs N
    BMJ Open; 2020 Sep; 10(9):e039449. PubMed ID: 32912994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Tie2 receptor antagonism in angiosarcoma.
    Hasenstein JR; Kasmerchak K; Buehler D; Hafez GR; Cleary K; Moody JS; Kozak KR
    Neoplasia; 2012 Feb; 14(2):131-40. PubMed ID: 22431921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
    Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
    Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X; Luo K; Lv Z; Huang J
    Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
    Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
    Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
    Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
    J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion.
    Annabi B; Lachambre MP; Plouffe K; Moumdjian R; Béliveau R
    Pharmacol Res; 2009 Nov; 60(5):438-45. PubMed ID: 19467330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.
    Wolter JK; Wolter NE; Blanch A; Partridge T; Cheng L; Morgenstern DA; Podkowa M; Kaplan DR; Irwin MS
    Oncotarget; 2014 Jan; 5(1):161-72. PubMed ID: 24389287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.
    Wang F; Liu H; Wang F; Xu R; Wang P; Tang F; Zhang X; Zhu Z; Lv H; Han T
    Mol Med Rep; 2018 Apr; 17(4):5213-5221. PubMed ID: 29393410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
    Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
    Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.
    Li P; Guo Z; Gao Y; Pan W
    Oncol Rep; 2015 Jun; 33(6):3099-107. PubMed ID: 25872592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
    Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
    Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.